Generic Drugs
In this section you will find Generic Drugs market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
World Generic Drug Market Outlook 2010-2025
€1,739.00Published by Visiongain on Sep 14th, 2010Where will the greatest opportunities for generic drug sales occur?Our new report will show you revenue prospects for the generic drug market from 2010 onwards. Where will the best... Learn More -
World Generics Market 2009-2024
€1,739.00Published by Visiongain on Aug 26th, 2009Impending patent expiries, increasing competition and changes in legislation: where will generics go from 2009 onwards? Our new report - World Generics Market 2009-2024 - explains the opportunities and challenges there. Learn More -
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
€1,739.00Published by Visiongain on Apr 16th, 2009There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success – our new report explains how. Learn More -
World Generics Market, 2008-2013
€1,739.00Published by Visiongain on Nov 24th, 2008This report provides details of these drugs and potential generics revenues. The study also identifies the therapeutic areas that will face the highest levels of competition from generic substitutes from 2008 to 2013. Learn More -
Generic League - Market Analysis and Forecasts, 2007-2012, 2017 & 2022
€1,739.00Published by Visiongain on Feb 27th, 2008The generic industry is a fast evolving market; with significant lucrative opportunities. The generic market is structurally set to experience high growth potential. That wave is partly driven by cost-containment in several national healthcare sectors and partly by the need for governments to promote the use of generic products over high-priced originator products without compromising quality. Learn More -
Teva Pharmaceutical Industries Market Forecasts & Analysis 2007-2012
€1,739.00Published by Visiongain on May 17th, 2007Teva Pharmaceutical Industries 2007-2012 examines that company critically, through comprehensive research and analysis. Learn More -
Dr. Reddys Market Outlook, Forecasts and Analysis to 2012
€1,739.00Published by Visiongain on Apr 11th, 2007Throughout 2007, Dr. Reddy’s has been jostling for leadership among the Indian companies, due to spectacular growth in recent quarters. This company is moving rapidly. Learn More -
The World Generics Market 2006-2011
€1,739.00Published by Visiongain on May 18th, 2006In sharp contrast to the branded pharmaceutical market, which has stalled in recent year, the generics market is enjoying a period of unprecedented success. In 2005 the world generics market was worth $45bn, a growth of 14% on the previous year... Learn More -
The Worlds Top Ten Generic Companies
€1,739.00Published by Visiongain on Nov 16th, 2005Generic companies and the drugs they produce are now an important part of the major pharmaceutical markets. The growth rate in the industry is increasing, nine of the top ten fastest growing pharmaceutical companies are generic and the demand for cheaper drugs is increasing. Learn More

